SlideShare una empresa de Scribd logo
1 de 18
TB or not TBPCR based Tuberculosis (TB) Detection on a Chip
Lael Wentland, Albert Nguyen, and Minjung Kim
Global Impact of TB
Mycobacterium tuberculosis
- ⅓ of world population infected with TB- latent or active
[1]
● Leading killer for HIV+
→ Difficult to diagnose in HIV+ patients
● Can be multi-drug resistant (MDR-TB)
● Difficult for young children to give sputum sample
● More accurate test → power supply, labratory, skilled professional
Other Factors Complicating TB Diagnosis
[2]
Engineering: Global Health Challenges
Living on Under $10 a Day
● Consider cost for where the
diagnostic is needed?
● Who will be doing the test? - >
shortage of health workers
○ Majority of work done by
individuals with less training
● Where will this diagnostic be done? -
higher level hospitals with electricity
● At what stage of the disease will people be
tested?- > ideally earlier
[3]
[2]
Method Pros Con
Culture ● the gold standard!
● allows genotyping of the
bacteria
● susceptibility testing
● prolonged time to result ( > 2 weeks)
● high cost with delayed diagnostics
● difficult to obtain patient samples
● $30 per test [5]
Acid Fast Stain ● rapid detection ● inadequate sensitivity/specificty
Interferon Gamma
-Release Assays
(IGRA)
● tests can be done in less
than 24 hours
● requires single patient visit
● need fresh blood samples
● test cannot be given to patient who has
been recently ( < 4-6 wks) vaccinated
● cost $160-290 [6]
Skin Test • Easy to administer ● cost around $55 [6] per test
Traditional PCR
PCR
● High sensitivtiy and
sensitivity
● Rapid detection time
● No transport requirement
● Allows detecton from non
invasive species
● Potential contamination
● Unable to assess viability
● Limited ability for genotype and
susceptibility testing
● $ 5-10 [7]
Current Diagnostic Methods for TB
Adapted from [4]
Final Clinical Diagnosis/Method Mycobacterial
Culture
PCR
Tuberculosis 19 Positive 10 Positive
8 Negative
1 Uncertain
14 Positive
5 Negative
Non-tuberculous
Mycobacterial
Infection
6 Negative 3 Positive
3 Negative
6 Negative
Nonmycobacteri
al infection
33 Negative 29 Negative
4 Uncertain
33 Negative
Uncertain 2 2 1 Positive
1 Negative
Side by Side Comparison of
Mycobacterial Culture and PCR
Sensitivity = true positives/(true positive + false negative)
Specificity = true negatives/(true negative + false positives)
[8]
Why use microfluidics for PCR?
● Portable
● Cost-effective
o does not require trained staff or
infrastructure
● species concentration can be
regulated in space and time
● quick and uniform heat and mass
transfer because of the high surface to
volume ratio
● increased speed and automation
opportunities that can potentially
reduce contamination
[12]
[11]
[10]
[9]
General Constraints
● Reach and hold 98C
● Material that will be heated by
PID controller
● Pass FDA 510(k) inspection
Global Health
Constraints
● Low cost
● Able to function in a variety
of environments-durable
● Easy to use and minimal
electricity
● Quick or immediate results
● Local Materials used
whenever possible**
+
● PID Controller:
○ must not deviate more than 0.5
Celsius from the set temperature
once it is reached
○ heat evenly throughout the resistor
○ minimize overshoot
● Be a more accurate TB diagnostic tool
than the ones currently available
○ sensitivity & specificity >= 95%
● Process patient sample in 1-2 hours
● 0.22 mm width with depth of 0.1 mm
● Cost < $9 per test
Specifications
[13]
[10]
Design
● Glass chip with etched channels
o Smooth curves
● Silicon Bottom
o High Conductivity
● 3 Thin-film Platinum heaters
o PID Controlled
● Cooling element unnecessary
Inlet
OutletTop View
Thin FIlm Platinum
Heaters/Sensors
Cross Section
Etched Glass Layer
Silicon Layer
How it Works
1. Sample with primer, nucleotides, and polymerase is fed into inlet
2. Enters Denaturation region ~ 95 C
3. Enters Annealing region ~68 C
4. Enters Elongation region ~72 C
5. Repeat
4
3
2
5
1
PID Control
● Run current through temperature sensitive platinum film
o Temperature detected as voltage drop
● PID controller finds error between set temperature and
detected temperature
● Converts error to duty cycle in heating film
● For quick response: kp = high
● For stability: ki = low, kd = high
[14]
PID Control: Results
● kp = 300, ki = 1, kd = 20
● Operating range not as narrow as desired
o Instrument limitations
● Overshoot and the steady state error reported 0.7 ◦C and ±0.1 ◦C,
respectively
User Input: 28 C
Operating Range: 27.5 - 29.5 C
User Input: 50 C
Operating Range: 48.5 - 52
Building and Testing Prototype
[11]
Testing
● Perform PCR with conventional methods and with chip then compare
results
Criteria for Success
● Reaction time must be shorter than with conventional method (~2.5 hrs)
● Operating range of +/- 0.5 C
● Cheap to make/use (< $9)
● High Specificity
o Prevent false negatives
Future Work
● Address contamination by
adding additional purification
chip
● Test on other disease
o viral, genetic, etc.
● Increase scale of production
o Plasmid production
● Test with better instruments with
higher sampling frequency
References
[1] "Global Tuberculosis Report 2014." WHO. Web. 7 Mar. 2015.
[2] TB Facts." Team:Paris Bettencourt/Human Practice/TB Fact. IGEM. Web. 7 Mar. 2015.
[3] "The New Worldmapper." Worldmapper: The World as You've Never Seen It before. The
University of Sheffield, 3 Jan. 2012. Web. 6 Mar. 2015.
[4] Yang S and Rothman RE. PCR-Based Diagnostics for infectious disease: uses, limitations, and
future applications in acute-care settings.
[5] Mueller DH, Mwenge L, Muyoyeta M, et al. “Costs and cost-effectiveness of tuerculosis cultures
using solid and liquid media in a developing country.” International Journal of Tuberculosis and Lung
Disease. 2008 Oct; 12(10):1196-202.
[6] de Perio MA, Tsewat J, et al. “Cost effectiveness of interferon gamma release assays vs.
tuberculin skin tests in health care workers.” JAMA Internal Medicine. 2009 Jan 26;169(2):179-87.
[7] Scherer LC, Sperhacke RD, Ruffino-Netto A, et al. “Cost-effectiveness analysis of PCR for the
rapid diagnosis of pulmonary tuberculosis.” BioMed Central Infectious Diseases. 2009, 9:216.
[8] Salian NV, Rish JA, Eisenach KD, et al. “Polymerase chain reaction to detect Mycobacterium
tuberculosis in histologic specimens.” American Journal of Respiratory and Critical Care Medicine
1998. Oct;158(4):1150-5.
[9] Shin YS, Cho K, Lim SH, et al. PDMS-based micro PCR chip with Parylene coating. Journal of
Micromechanics and microengineering. 2003. June;13:(5):768-774.
[10] Kim J, Byun D, Mauk MG, et al. “A Disposable, Self-Contained PCR Chip.” Lab Chip. 2009 Feb
21; 9(4):606-612.
References (continued)
[11] Schneegass I, Brautigam R, Kohler JM. “Miniaturized flow-through PCR with different template
types in a silicon chip thermocycler. Lab Chip. 2001 Sep;1(1):42-9.
[12] Oblath EA, Henley WH, Alarie JP, et al. “A microfluidic chip integrating DNA extraction and real
time PCR for the detection of bacteria in saliva. Lab Chip. 2013 Apr 7;13(7):1325-32.
[13] Yoon DS, Lee YS, Lee Y, et al. “Precise temperature control and rapid thermal cycling in a
micro-machined DNA polymerase chain reaction chip.” Journal of Micromechanics and
Microengineering. 2002 Oct; 12(6): 813-823.
[14] "PID Control." PidHingeController. Tin-man, 5 Apr. 2012. Web. 6 Mar. 2015.
<https://code.google.com/p/tin-man/wiki/PidHingeController>.

Más contenido relacionado

Similar a Kim Nguyen Wentland BIOEN 337 Presentation Final

Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...pateldrona
 
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...clinicsoncology
 
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...georgemarini
 
PPT MOLECULAR DIG gram +ve bacteria.....
PPT MOLECULAR DIG gram +ve bacteria.....PPT MOLECULAR DIG gram +ve bacteria.....
PPT MOLECULAR DIG gram +ve bacteria.....Dr. Ajit Surya Singh
 
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersMolecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersWAidid
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPnavinthakkar
 
Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsBruno Mmassy
 
Koch To Quantiferon
Koch To QuantiferonKoch To Quantiferon
Koch To Quantiferonjamieritchey
 
New technologies in point-of-care nucleic acid tests
New technologies in point-of-care nucleic acid testsNew technologies in point-of-care nucleic acid tests
New technologies in point-of-care nucleic acid testsPaolo Dametto
 
PCT for Antimicrobial Stewardship.pptx
PCT for Antimicrobial Stewardship.pptxPCT for Antimicrobial Stewardship.pptx
PCT for Antimicrobial Stewardship.pptxConrad Strydom
 
Hiv Presentation Asicon
Hiv Presentation AsiconHiv Presentation Asicon
Hiv Presentation Asiconzmanian
 
Innovation in Affordable CD4 Enumeration Diagnostics
Innovation in Affordable CD4 Enumeration DiagnosticsInnovation in Affordable CD4 Enumeration Diagnostics
Innovation in Affordable CD4 Enumeration DiagnosticsAnand Sivaraman
 
Newer Diagnostic Modality in Tuberculosis.pptx
Newer Diagnostic Modality in Tuberculosis.pptxNewer Diagnostic Modality in Tuberculosis.pptx
Newer Diagnostic Modality in Tuberculosis.pptxBIMALESHYADAV2
 
Investigative options covid 19
Investigative options covid  19 Investigative options covid  19
Investigative options covid 19 Sumi Nandwani
 
691632.ppt
691632.ppt691632.ppt
691632.pptShinee13
 

Similar a Kim Nguyen Wentland BIOEN 337 Presentation Final (20)

POCT-1.pptx
POCT-1.pptxPOCT-1.pptx
POCT-1.pptx
 
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
 
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
 
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
Loop –Mediated Isothermal Amplification (LAMP) Based POINT-OF-CARE for Rapid ...
 
PPT MOLECULAR DIG gram +ve bacteria.....
PPT MOLECULAR DIG gram +ve bacteria.....PPT MOLECULAR DIG gram +ve bacteria.....
PPT MOLECULAR DIG gram +ve bacteria.....
 
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersMolecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCP
 
Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology bls
 
Koch To Quantiferon
Koch To QuantiferonKoch To Quantiferon
Koch To Quantiferon
 
New technologies in point-of-care nucleic acid tests
New technologies in point-of-care nucleic acid testsNew technologies in point-of-care nucleic acid tests
New technologies in point-of-care nucleic acid tests
 
PCT for Antimicrobial Stewardship.pptx
PCT for Antimicrobial Stewardship.pptxPCT for Antimicrobial Stewardship.pptx
PCT for Antimicrobial Stewardship.pptx
 
Hiv Presentation Asicon
Hiv Presentation AsiconHiv Presentation Asicon
Hiv Presentation Asicon
 
Innovation in Affordable CD4 Enumeration Diagnostics
Innovation in Affordable CD4 Enumeration DiagnosticsInnovation in Affordable CD4 Enumeration Diagnostics
Innovation in Affordable CD4 Enumeration Diagnostics
 
Dr Xin wang
Dr Xin wangDr Xin wang
Dr Xin wang
 
Ismail AJRCCM 2015
Ismail AJRCCM 2015Ismail AJRCCM 2015
Ismail AJRCCM 2015
 
Newer Diagnostic Modality in Tuberculosis.pptx
Newer Diagnostic Modality in Tuberculosis.pptxNewer Diagnostic Modality in Tuberculosis.pptx
Newer Diagnostic Modality in Tuberculosis.pptx
 
Investigative options covid 19
Investigative options covid  19 Investigative options covid  19
Investigative options covid 19
 
691632.ppt
691632.ppt691632.ppt
691632.ppt
 
Recent advances in TB diagnosis
Recent advances in TB diagnosisRecent advances in TB diagnosis
Recent advances in TB diagnosis
 
Invest to End TB. Save Lives
Invest to End TB. Save LivesInvest to End TB. Save Lives
Invest to End TB. Save Lives
 

Kim Nguyen Wentland BIOEN 337 Presentation Final

  • 1. TB or not TBPCR based Tuberculosis (TB) Detection on a Chip Lael Wentland, Albert Nguyen, and Minjung Kim
  • 2. Global Impact of TB Mycobacterium tuberculosis - ⅓ of world population infected with TB- latent or active [1]
  • 3. ● Leading killer for HIV+ → Difficult to diagnose in HIV+ patients ● Can be multi-drug resistant (MDR-TB) ● Difficult for young children to give sputum sample ● More accurate test → power supply, labratory, skilled professional Other Factors Complicating TB Diagnosis [2]
  • 4. Engineering: Global Health Challenges Living on Under $10 a Day ● Consider cost for where the diagnostic is needed? ● Who will be doing the test? - > shortage of health workers ○ Majority of work done by individuals with less training ● Where will this diagnostic be done? - higher level hospitals with electricity ● At what stage of the disease will people be tested?- > ideally earlier [3] [2]
  • 5. Method Pros Con Culture ● the gold standard! ● allows genotyping of the bacteria ● susceptibility testing ● prolonged time to result ( > 2 weeks) ● high cost with delayed diagnostics ● difficult to obtain patient samples ● $30 per test [5] Acid Fast Stain ● rapid detection ● inadequate sensitivity/specificty Interferon Gamma -Release Assays (IGRA) ● tests can be done in less than 24 hours ● requires single patient visit ● need fresh blood samples ● test cannot be given to patient who has been recently ( < 4-6 wks) vaccinated ● cost $160-290 [6] Skin Test • Easy to administer ● cost around $55 [6] per test Traditional PCR PCR ● High sensitivtiy and sensitivity ● Rapid detection time ● No transport requirement ● Allows detecton from non invasive species ● Potential contamination ● Unable to assess viability ● Limited ability for genotype and susceptibility testing ● $ 5-10 [7] Current Diagnostic Methods for TB Adapted from [4]
  • 6. Final Clinical Diagnosis/Method Mycobacterial Culture PCR Tuberculosis 19 Positive 10 Positive 8 Negative 1 Uncertain 14 Positive 5 Negative Non-tuberculous Mycobacterial Infection 6 Negative 3 Positive 3 Negative 6 Negative Nonmycobacteri al infection 33 Negative 29 Negative 4 Uncertain 33 Negative Uncertain 2 2 1 Positive 1 Negative Side by Side Comparison of Mycobacterial Culture and PCR Sensitivity = true positives/(true positive + false negative) Specificity = true negatives/(true negative + false positives) [8]
  • 7. Why use microfluidics for PCR? ● Portable ● Cost-effective o does not require trained staff or infrastructure ● species concentration can be regulated in space and time ● quick and uniform heat and mass transfer because of the high surface to volume ratio ● increased speed and automation opportunities that can potentially reduce contamination [12] [11] [10] [9]
  • 8. General Constraints ● Reach and hold 98C ● Material that will be heated by PID controller ● Pass FDA 510(k) inspection Global Health Constraints ● Low cost ● Able to function in a variety of environments-durable ● Easy to use and minimal electricity ● Quick or immediate results ● Local Materials used whenever possible** +
  • 9. ● PID Controller: ○ must not deviate more than 0.5 Celsius from the set temperature once it is reached ○ heat evenly throughout the resistor ○ minimize overshoot ● Be a more accurate TB diagnostic tool than the ones currently available ○ sensitivity & specificity >= 95% ● Process patient sample in 1-2 hours ● 0.22 mm width with depth of 0.1 mm ● Cost < $9 per test Specifications [13] [10]
  • 10. Design ● Glass chip with etched channels o Smooth curves ● Silicon Bottom o High Conductivity ● 3 Thin-film Platinum heaters o PID Controlled ● Cooling element unnecessary Inlet OutletTop View Thin FIlm Platinum Heaters/Sensors Cross Section Etched Glass Layer Silicon Layer
  • 11. How it Works 1. Sample with primer, nucleotides, and polymerase is fed into inlet 2. Enters Denaturation region ~ 95 C 3. Enters Annealing region ~68 C 4. Enters Elongation region ~72 C 5. Repeat 4 3 2 5 1
  • 12. PID Control ● Run current through temperature sensitive platinum film o Temperature detected as voltage drop ● PID controller finds error between set temperature and detected temperature ● Converts error to duty cycle in heating film ● For quick response: kp = high ● For stability: ki = low, kd = high [14]
  • 13. PID Control: Results ● kp = 300, ki = 1, kd = 20 ● Operating range not as narrow as desired o Instrument limitations ● Overshoot and the steady state error reported 0.7 ◦C and ±0.1 ◦C, respectively User Input: 28 C Operating Range: 27.5 - 29.5 C User Input: 50 C Operating Range: 48.5 - 52
  • 14. Building and Testing Prototype [11]
  • 15. Testing ● Perform PCR with conventional methods and with chip then compare results Criteria for Success ● Reaction time must be shorter than with conventional method (~2.5 hrs) ● Operating range of +/- 0.5 C ● Cheap to make/use (< $9) ● High Specificity o Prevent false negatives
  • 16. Future Work ● Address contamination by adding additional purification chip ● Test on other disease o viral, genetic, etc. ● Increase scale of production o Plasmid production ● Test with better instruments with higher sampling frequency
  • 17. References [1] "Global Tuberculosis Report 2014." WHO. Web. 7 Mar. 2015. [2] TB Facts." Team:Paris Bettencourt/Human Practice/TB Fact. IGEM. Web. 7 Mar. 2015. [3] "The New Worldmapper." Worldmapper: The World as You've Never Seen It before. The University of Sheffield, 3 Jan. 2012. Web. 6 Mar. 2015. [4] Yang S and Rothman RE. PCR-Based Diagnostics for infectious disease: uses, limitations, and future applications in acute-care settings. [5] Mueller DH, Mwenge L, Muyoyeta M, et al. “Costs and cost-effectiveness of tuerculosis cultures using solid and liquid media in a developing country.” International Journal of Tuberculosis and Lung Disease. 2008 Oct; 12(10):1196-202. [6] de Perio MA, Tsewat J, et al. “Cost effectiveness of interferon gamma release assays vs. tuberculin skin tests in health care workers.” JAMA Internal Medicine. 2009 Jan 26;169(2):179-87. [7] Scherer LC, Sperhacke RD, Ruffino-Netto A, et al. “Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis.” BioMed Central Infectious Diseases. 2009, 9:216. [8] Salian NV, Rish JA, Eisenach KD, et al. “Polymerase chain reaction to detect Mycobacterium tuberculosis in histologic specimens.” American Journal of Respiratory and Critical Care Medicine 1998. Oct;158(4):1150-5. [9] Shin YS, Cho K, Lim SH, et al. PDMS-based micro PCR chip with Parylene coating. Journal of Micromechanics and microengineering. 2003. June;13:(5):768-774. [10] Kim J, Byun D, Mauk MG, et al. “A Disposable, Self-Contained PCR Chip.” Lab Chip. 2009 Feb 21; 9(4):606-612.
  • 18. References (continued) [11] Schneegass I, Brautigam R, Kohler JM. “Miniaturized flow-through PCR with different template types in a silicon chip thermocycler. Lab Chip. 2001 Sep;1(1):42-9. [12] Oblath EA, Henley WH, Alarie JP, et al. “A microfluidic chip integrating DNA extraction and real time PCR for the detection of bacteria in saliva. Lab Chip. 2013 Apr 7;13(7):1325-32. [13] Yoon DS, Lee YS, Lee Y, et al. “Precise temperature control and rapid thermal cycling in a micro-machined DNA polymerase chain reaction chip.” Journal of Micromechanics and Microengineering. 2002 Oct; 12(6): 813-823. [14] "PID Control." PidHingeController. Tin-man, 5 Apr. 2012. Web. 6 Mar. 2015. <https://code.google.com/p/tin-man/wiki/PidHingeController>.

Notas del editor

  1. one-third of the world’s population is infected with TB TB is spread from person to person through the air A person needs to inhale only a few of these germs to become infected. Over 95% of TB deaths occur in low- and middle-income countries, and it is among the top 5 causes of death for women aged 15 to 44 General goal in Global health efforts: reduce incidence, prevalence and mortality of tuberculosis http://www.who.int/mediacentre/factsheets/fs104/en/ common diagnostic is speutum to test for lung TB (most common)- look at under microscope
  2. Globally in 2013, an estimated 480 000 people developed multidrug resistant TB (MDR-TB) http://www.msfaccess.org/our-work/tuberculosis/article/1534
  3. -low income countries have little support for healthcare-out of own pocket 50-100% -Severe shortage of health workers in these counties, 2.28 doctors, nurses, and midwives per 1,000 population but in africa /southeast asiait is often -These are also the countries with high HIV prevalence and increasing number of patients on HIV retroviral drugs -mostly needed for HIV+ people because current tests are not great
  4. http://www.cdc.gov/tb/education/corecurr/pdf/chapter4.pdf Taegtmeyer M, et al. Thorax 2008;63:317‐21 SMEAR STUFF
  5. http://www.atsjournals.org/doi/full/10.1164/ajrccm.158.4.9802034#.VPyuUfnF9TY http://www.atsjournals.org/doi/pdf/10.1164/ajrccm.158.4.9802034
  6. http://www.nature.com/nrd/journal/v5/n3/pdf/nrd1985.pdf http://blogs.nature.com/spoonful/2013/01/blue-sky-hiv-test-chip-will-upload-results-to-the-cloud.html back in 2011, researchers in Columbia University successfully built a microfluidic chip to detect HIV in 15 minutes with 100% sensitivity and 96% specificity for less than $1
  7. FDA notes: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm357617.htm8 ** This is for if the main chip can be 3D printed possibly in that area(to create/support economy) but the pcr reagents can be shipped. I am not so sure if there are more general constraints-we can move them around from specs if needed
  8. Top left: PDMS based PCR: 94 C for 15 s, 58 C for 15 s and 72 C for 30 s Top right: Precise Temp Control: Moreover, the overshoot is not over 0.7 ◦C and the steady-state error is less than ±0.1 ◦C. Rapid thermal cycling that takes 6 s per cycle can be demonstrated. After all, for 30 cycles, only 3 min are required, which is about 20 times shorter than conventional thermal cycling. Bottom left: Disposable: The thermal cycling was performed by an initial denaturing step at 94 C for 1 min followed by 35 cycles (denaturation: 94 C, 20 s; annealing: 60 C, 20 s; extension: 72 C, 40 s), with a final extension at 72 C for 3 min. The thermal cycling time was not optimized and can potentially be significantly shortened.
  9. building and testing prototype